About VanguardBIO — Built by Someone Who Refused to Compromise

Our Story

Built by Someone
Who Refused
to Compromise.

VanguardBIO was not founded in a boardroom. It was built in a training gym, a recovery room, and a decade of obsessive research into what actually works.

David Skul, Founder & CEO, VanguardBIO

David Skul and Wife Amy Skul

Founder & CEO, VanguardBIO

35+

Years Training

6

Compounds Tested

50

States Served

503B

Sourced Only

The Founder

I Had Everything I Worked For.
My Body Was the Only Thing Failing Me.

By 2022, I had everything I had worked for. Successful business. Retired at 52. The woman I love beside me. On paper, nothing was wrong.

In reality, I was suffering. Chronic fatigue. Constant pain. A diagnosis of pre-Parkinson's disease. I had been a high-level weightlifting and conditioning athlete my entire adult life — and had recently begun jiu-jitsu, working toward the end of my blue belt. But decades of high-level athleticism, traumatic brain injuries, accidents, and an unhealthy gut had caught up with me. I was old and worn out in a body that used to be my greatest asset.

My health experts recommended surgeries, stem cell injections, and a range of other interventions to address the constant pain. I was not willing to accept that as the answer. But I did engage in stem cell injections and drip therapy — and the results were significant. My injuries began to resolve. And the pre-Parkinson's diagnosis was eliminated entirely. The plaque and scarring in my brain — caused by an unhealthy gut and a lifetime of traumatic brain injuries — was gone.

That outcome changed everything I thought I knew about what was possible. It sent me deep into the research on peptides, neuroprotection, and cellular repair. I found that the compounds existed to address what I had been experiencing — but the sourcing was unreliable, the guidance was anecdotal, and there was no trustworthy protocol built for someone like me.

VanguardBIO exists to be that protocol. Medical-grade sourcing. Health expert oversight. Built on evidence, not marketing. For people who have already achieved everything — and refuse to let their biology be the thing that takes it away.

The Path

How We Got Here

2022

Retired at 52 after a successful business career. Despite achieving everything on paper, was suffering from chronic fatigue, constant pain, and a diagnosis of pre-Parkinson's disease. Still competing in jiu-jitsu at blue belt level.

2022

Engaged in stem cell injections and drip therapy after conventional health experts recommended surgery and injections. The pre-Parkinson's diagnosis was eliminated entirely — plaque and scarring in the brain, caused by an unhealthy gut and a lifetime of traumatic brain injuries, resolved completely.

2023

Began deep research into peptide pharmacology, neuroprotection, and cellular repair. Built relationships with 503B compounding pharmacies, endocrinologists, and biochemists. Assembled a scientific advisory board.

2024

Spent 18 months developing and personally testing the six-compound protocol stack. Tracked every biomarker. Documented every result. Identified the sourcing gap — no trustworthy, medical-grade option existed for people who needed it most.

2025

Founded VanguardBIO. First members were former training partners, health experts, and colleagues. Zero marketing. All word of mouth.

2026

Serving members globally. Still personally reviews every protocol. Still trains daily.

Our Mission

The Standard We Hold Ourselves To

No Compromises on Source

Every compound is sourced exclusively from licensed 503B outsourcing facilities. No grey-market suppliers. No overseas manufacturers. No exceptions.

Health Expert-Supervised Only

Every member completes a health expert consultation before their first order. We are not a supplement company. We operate like a medical practice.

Transparency Over Marketing

We publish our full compound list, dosing rationale, and sourcing standards. If we cannot explain why something is in the protocol, it is not in the protocol.

Results Are the Only Metric

We track biomarkers, not testimonials. Every protocol adjustment is data-driven. We are building a longitudinal dataset on peptide performance that does not exist anywhere else.

Scientific Advisory Board

The Minds Behind the Protocol

Every compound, every dose, every sourcing decision is reviewed by our advisory board. These are not honorary titles. They are active collaborators.

Dr. Elena Vasquez, MD, PhD

Chief Medical Advisor

Board-certified endocrinologist. Former research fellow, Stanford Center for Longevity. 20+ peer-reviewed publications on peptide signaling and metabolic optimization.

Dr. James Okafor, PhD

Director of Peptide Research

Biochemist specializing in growth hormone secretagogues. Former principal investigator, NIH-funded tissue repair program. Co-inventor on 3 patents in regenerative peptide delivery.

Dr. Sarah Lindqvist, MD

Neurological Performance Advisor

Neurologist and cognitive performance specialist. Clinical research in nootropic peptides (Semax, Selank) at the Karolinska Institute. Advisor to two elite military performance programs.

Dr. Marcus Chen, PharmD

Compounding & Quality Advisor

503B outsourcing facility compliance expert. 18 years in sterile pharmaceutical compounding. Ensures every VanguardBIO formulation meets USP <797> and <800> standards.

Ready?

Two Protocols. One Standard.

Health expert-supervised. 503B sourced. Rapid delivery. $549/month. No compromises — on either stack.

Performance

Vanguard Protocol

BPC-157, TB-500, HGH, Semax, Selank, Retatrutide

Subscribe

Longevity

Longevity Protocol

Glutathione, GHK-Cu, NAD+, TB-500, Melanotan II, HGH

Subscribe
Review the Science
VanguardBIO

© 2026 VanguardBIO. All rights reserved.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a health expert before beginning any peptide protocol. For use by adults 18 years and older only.